Venous Leg Ulcers
28
2
4
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
3.6%
1 terminated out of 28 trials
92.3%
+5.8% vs benchmark
25%
7 trials in Phase 3/4
50%
6 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (28)
Subcutaneous Dexpanthenol Administration and Wound Epithelialization
Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUs
Chemical Debridement and Leg Ulcers
Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery
Wound Healing Endpoint and Recurrence
A RCT Evaluating Efficacy of Type-I Collagen Skin Substitute vs. Human Amnion Membrane in Treatment of Venous Leg Ulcers
Topical Timolol Benefit in Venous Ulcers
Educational Interventions in Venous Leg Ulcer
Evaluating Intact Fish Skin Graft and Standard of Care Versus Standard of Care Alone in Nonhealing Venous Leg Ulcers
Clinical Trial Evaluating an Amnion Membrane Allograft Intended for Use in the Management of Non- Healing Venous Leg Ulcers Versus Standard Of Care Alone
Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers
Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)
Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers
Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Effectiveness of Aurix Therapy in Venous Leg Ulcers
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers